Provider Directory
5 Diamond Safety Program
Fistula First Vascular Access
Upper Midwest Fistula First CoalitionSite Search
Powered by
Dialysis Facility CompareMedical Review Committee
Recommended Treatment Goals and Review Guidelines for Dialysis Facilities
The mission of ESRD Network 11 is to assess and improve the quality of care provided to individuals with end-stage renal disease. In keeping with this mission statement, the Medical Review Committee (MRC) issues its recommended treatment goals on important clinical parameters. These parameters are based on available evidence and accepted practice guidelines such as K/DOQI (Kidney Dialysis Outcomes Quality Initiative), etc. These improvement goals are provided as assistance to dialysis facilities for use in quality improvement. Each year, the MRC reviews its recommended treatment guidelines and makes revisions based on changes in clinical practice guidelines.
Changes for 2012
- Laboratory value used for analysis. Network 11 will begin to use the last lab value of the month in its analysis. This will correspond with the lab values used for reimbursement as well as for Crown Web.
- Anemia Management. In October 2011, Network 11 sent a letter describing the new recommendations for anemia management. Those recommendations have been included in the MRC Guidelines document. The MRC will be reviewing Q4 2011 data from facilities to determine further recommendations.
- PTH monitoring. While Network 11 does not collect iPTH lab data as part of its Elab project, the MRC continues to consider iPTH monitoring a very important part of the management of bone and mineral metabolism. Therefore, the MRC now recommends that 100% of patients should have iPTH concentration measured at least quarterly.
- AVF Goal. The goal for prevalent AVFs has been increased slightly from 65% to 66%. This change is made to match the CMS national goal of 66%.
View the recommended treatment goals and review guidelines for transplant facilities.
(Link to Adobe Web site opens in new window.)